# A Study of Efficacy and Safety With the Transdermal Contraceptive System.

> **NCT00236769** · PHASE3 · COMPLETED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.** · enrollment: 1751 (actual)

## Conditions studied

- Contraception
- Female Contraception

## Interventions

- **DRUG:** norelgestromin + ethinyl estradiol

## Key facts

- **NCT ID:** NCT00236769
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-11
- **Primary completion:** —
- **Final completion:** 1999-10
- **Target enrollment:** 1751 (ACTUAL)
- **Last updated:** 2010-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00236769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00236769, "A Study of Efficacy and Safety With the Transdermal Contraceptive System.". Retrieved via AI Analytics 2026-07-30 from https://api.ai-analytics.org/clinical/NCT00236769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*